Proinsulin-to-C-Peptide Ratio Linked to Progression to T1DM

Share this content:
Proinsulin-to-C-Peptide Ratio Linked to Progression to T1DM
Proinsulin-to-C-Peptide Ratio Linked to Progression to T1DM

TUESDAY, July 19, 2016 (HealthDay News) -- Elevation in the serum proinsulin-to-C-peptide (PI:C) ratio is associated with progression to type 1 diabetes, according to a study published online July 6 in Diabetes Care.

Emily K. Sims, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues examined whether elevation in the PI:C ratio correlated with type 1 diabetes. Samples were obtained about 12 months before onset of diabetes from 60 TrialNet Pathway to Prevention progressors in whom diabetes developed and 58 age-, sex-, and body mass index (BMI)-matched nonprogressors who remained normoglycemic.

The researchers found that, compared with nonprogressors, there was a significant increase in PI:C ratios in antibody-positive subjects in whom there was progression to diabetes (median, 1.81 versus 1.17 percent; P = 0.03). Subjects who were ≤10 years old had the most pronounced difference between groups; 90 percent of subjects in this age group within the upper PI:C ratio quartile progressed to diabetes development. The odds of progression were increased for higher natural log PI:C ratio values after adjustment for age and BMI (odds ratio, 1.44).

"These data suggest that β-cell endoplasmic reticulum dysfunction precedes type 1 diabetes onset, especially in younger children," the authors write. "Elevations in the serum PI:C ratio may have utility in predicting the onset of type 1 diabetes in the presymptomatic phase."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »